Written question asked by Cheryl Gillan (Conservative) on Wednesday, 18 December 2002, in the House of Commons. It was due for an answer on Tuesday, 7 January 2003. It was answered by Hazel Blears (Labour) on Tuesday, 7 January 2003 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, what assessment he has made of how the pharmaceutical production and testing standards for products under the draft Traditional Herbal Medicinal Products Directive will affect the commercial value of the products on the UK market, with special reference to those produced by smaller specialist companies and distributed through specialist retailers; what assessment he has made of how the fees charged by the Medicines Control Agency for considering applications for the registration of herbal products under the terms of the proposed Traditional Herbal Medicinal Products Directive will affect the commercial value of the products on the UK market, with particular reference to those produced by smaller specialist companies and distributed through specialist retailers.

Secondary information

Type: Written question
Reference: 397 c191-2W; 88690;88691
Session: 2002-03
Subjects: Companies Applications Complementary medicine Fees and charges EU action Registration Standards Small businesses Retail trade Testing Herbal medicine
Link: View this Written question on www.publications.parliament.uk